Brief: Viveve Rebranding Initiative Focusing On Treatment Of Female Stress Urinary Incontinence In Anticipation Of U.S. Pivotal Pursuit Trial Readout
Sept 27 (Reuters) - Viveve Medical Inc VIVE.O :
* VIVEVE - REBRANDING INITIATIVE FOCUSING ON TREATMENT OF
FEMALE
STRESS URINARY INCONTINENCE IN ANTICIPATION OF U.S. PIVOTAL
PURSUIT TRIAL READOUT
* VIVEVE MEDICAL - COMPLETION OF PURSUIT FOLLOW-UP VISITS
ANTICIPATED BY THE END OF 2022 WITH TOPLINE RESULTS EXPECTED
SHORTLY THEREAFTER
Further company coverage: VIVE.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Viveve Medical
See all newsU.S. STOCKS ON THE MOVE-Chord Energy, Kroger, PetMed Express
U.S. STOCKS ON THE MOVE-DoorDash, Walt Disney, Tesla
U.S. STOCKS ON THE MOVE-Papa John's, Whirlpool, Coca-Cola
Viveve Medical plunges as urinary disease drug fails to meet main goal
Brief: Viveve Medical Inc - Company Will Seek Strategic Alternatives And Will Be Delisted From Nasdaq